Home / Resources / Conferences / 3rd Annual Gene Therapy
for Neurological Disorders

3rd Annual Gene Therapy
for Neurological Disorders

3rd Annual Gene Therapyfor Neurological Disorders
Presentation(s)
How Regulatory-ready Biosimulation Advances Pre-clinical and Clinical CNS Drug Development
Piet van der Graaf | SVP Quantitative Science Services
• Predict dose-response relationship between administered viral load and target protein expression • For Gene Therapy and Neurological Diseases, these tools increase confidence around dosing, immunogenicity, and special populations • QSP modeling using virtual patients/trials supported by global regulators
Back to top